• Markets
    • icon
  • Companies
AMT · ASX

Allegra Medical Technologies Limited (ASX:AMT)

AU$0.05

 0.0 (0.0%)
ASX:Live
08/12/2023 12:00:00 AM
HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

AMT Overview

AMT Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

AMT Price Chart

Key Stats

Market Cap

n/a

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.0 - 0.0

Trade Value (12mth)

N/A

1 week

-9.09%

1 month

38.89%

YTD

-50%

1 year

-52.38%

All time high

N/A

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Other Data

Shares on Issue (Fully Dilluted)

N/A

HALO Sector

Healthcare

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

N/A

Short Sell (% of issue)

N/A

AMT Announcements

Latest Announcements

Date Announcements

31 October 22

2022 AGM Letter to Shareholders and Proxy

×

2022 AGM Letter to Shareholders and Proxy

31 October 22

2022 AGM Notice of Meeting and Proxy

×

2022 AGM Notice of Meeting and Proxy

31 January 22

Large Animal Study Shows Positive Results

×

Large Animal Study Shows Positive Results

31 August 23

Appendix 4E and Annual Report

×

Appendix 4E and Annual Report

31 August 23

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

30 September 19

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

30 September 19

Annual Report to shareholders

×

Annual Report to shareholders

30 November 22

Results of Meeting

×

Results of Meeting

30 November 22

Constitution

×

Constitution

30 August 23

Results of Pro-Rata Non-Renounceable Entitlement Offer

×

Results of Pro-Rata Non-Renounceable Entitlement Offer

29 September 23

2023 AGM - Notice of Meeting, Letter of Access and Proxy

×

2023 AGM - Notice of Meeting, Letter of Access and Proxy

29 October 21

Annual Report to shareholders

×

Annual Report to shareholders

28 September 23

Spinal Cage FDA Submission Timeline Update

×

Spinal Cage FDA Submission Timeline Update

28 June 23

Extension of Loan Agreement with RIPL

×

Extension of Loan Agreement with RIPL

28 August 23

Completion of Sale of the Orthopaedic Division

×

Completion of Sale of the Orthopaedic Division

25 September 20

Annual Report to shareholders

×

Annual Report to shareholders

25 September 20

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

24 July 23

2023 General Meeting Letter of Access and Proxy

×

2023 General Meeting Letter of Access and Proxy

24 July 23

EGM Notice of Meeting and Proxy

×

EGM Notice of Meeting and Proxy

24 February 23

Appendix 4D and Half Year Financial Report

×

Appendix 4D and Half Year Financial Report

23 September 22

Date of Annual General Meeting 2022

×

Date of Annual General Meeting 2022

23 August 23

Results of Meeting

×

Results of Meeting

22 February 23

Large Animal Study Completed Showing Positive Results

×

Large Animal Study Completed Showing Positive Results

20 October 23

Unlisted Options Expiring

×

Unlisted Options Expiring

19 July 23

Rights Issue & Update on Sale of Orthopaedic Asset

×

Rights Issue & Update on Sale of Orthopaedic Asset

19 July 23

Pro Rata Non-Renounceable Entitlement Offer Booklet

×

Pro Rata Non-Renounceable Entitlement Offer Booklet

19 July 23

Letter to Ineligible Shareholders

×

Letter to Ineligible Shareholders

19 July 23

Letter to Option Holder

×

Letter to Option Holder

AMT Fundamentals

Per Share Records

Historical data

Forecasted data

2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) AU$ Lock Lock Lock Lock -0.01 -0.02 -0.03 Lock Lock Lock
EPS (Fully Diluted) AU$ Lock Lock Lock Lock -0.01 -0.02 -0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock 52.1 -333.9 -43.6 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS AU$ Lock Lock Lock Lock 0.00 -0.01 -0.01 Lock Lock Lock
FCFPS AU$ Lock Lock Lock Lock -0.00 -0.02 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 106.3 -2,068.0 20.5 Lock Lock Lock
     Yield % Lock Lock Lock Lock -1.9 -10.4 -13.8 Lock Lock Lock
DPS AU$ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS AU$ Lock Lock Lock Lock 0.04 0.02 -0.01 Lock Lock Lock
BPS (Tangible) AU$ Lock Lock Lock Lock 0.04 0.02 -0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock -15.7 -58.8 -219.4 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 104 104 104 Lock Lock Lock
Basic m Lock Lock Lock Lock 104 104 104 Lock Lock Lock

Financial Records

Historical data

Forecasted data

2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales AU$m Lock Lock Lock Lock 5 3 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock -10.2 -34.8 -100.0 Lock Lock Lock
Selling & General Expenses AU$m Lock Lock Lock Lock 5 5 2 Lock Lock Lock
Gross Income AU$m Lock Lock Lock Lock 3 1 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock -9.4 -51.2 -118.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock 58.4 43.7 N/A Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 42 56 0 Lock Lock Lock
EBITDA AU$m Lock Lock Lock Lock -2 -3 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock -0.1 -52.4 21.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -41.1 -96.2 N/A Lock Lock Lock
Depreciation & Amortisation AU$m Lock Lock Lock Lock 1 1 0 Lock Lock Lock
EBIT AU$m Lock Lock Lock Lock -2 -3 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock -2.3 -43.6 27.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -52.6 -116.0 N/A Lock Lock Lock
Pretax Income AU$m Lock Lock Lock Lock -2 -3 -3 Lock Lock Lock
Income Taxes AU$m Lock Lock Lock Lock -1 -1 -1 Lock Lock Lock
Net Income AU$m Lock Lock Lock Lock -1 -3 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock 50.3 -338.0 -43.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -12.9 -86.4 N/A Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow AU$m Lock Lock Lock Lock 0 -2 -1 Lock Lock Lock
Capital Expenditures AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow AU$m Lock Lock Lock Lock 0 2 0 Lock Lock Lock
Free Cash Flow AU$m Lock Lock Lock Lock 0 -2 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -23.1 -397.5 59.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.1 -0.7 N/A Lock Lock Lock
Franking Balance AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Total Assets AU$m Lock Lock Lock Lock 6 6 3 Lock Lock Lock
Long Term Debt AU$m Lock Lock Lock Lock 0 2 3 Lock Lock Lock
Net Debt AU$m Lock Lock Lock Lock 0 2 3 Lock Lock Lock
Total Liabilities AU$m Lock Lock Lock Lock 2 3 4 Lock Lock Lock
Equity AU$m Lock Lock Lock Lock 5 2 -1 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 5 4 1 Lock Lock Lock
     Growth % Lock Lock Lock Lock 2.5 -14.1 -70.6 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -9.1 -45.2 -125.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -12.7 -118.9 243.3 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -49.2 -72.4 -80.8 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -12.6 -58.6 -80.6 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -7.9 -43.0 -29.9 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -140.0 -21.0 -7.4 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.0 -0.8 -1.4 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -0.2 99.7 -208.5 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 3.0 2.8 1.3 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 1.1 1.0 1.3 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 7.5 4.7 0.1 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -22.6 -118.2 -45.2 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 3.3 2.4 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 0.6 0.6 0.2 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 1.4 1.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 20.1 22.4 0.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.7 0.5 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.7 0.5 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -39.2 -116.6 0.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -27.9 -61.0 0.0 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -9.1 -45.2 -125.2 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.4 2.6 -1.9 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -12.7 -118.9 243.3 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -12.7 -118.9 243.3 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 608.6 647.9 2,146.9 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 109.8 153.8 0.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 718.4 801.7 2,146.9 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 216.1 192.6 0.0 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 502.2 609.1 2,146.9 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

AMT Shortsell

Frequently Asked Questions

The current share price of Allegra Medical Technologies Limited (AMT:ASX) is AU$0.05.
The 52-week high share price for Allegra Medical Technologies Limited (AMT:ASX) is AU$0.00.
The 52-week low share price for Allegra Medical Technologies Limited (AMT:ASX)? is AU$0.00.
Allegra Medical Technologies Limited (AMT:ASX) does not pay a dividend.
Allegra Medical Technologies Limited (AMT:ASX) does not pay a dividend.
Allegra Medical Technologies Limited (AMT:ASX) does not offer franking credits.
Allegra Medical Technologies Limited (AMT:ASX) is classified in the Healthcare.
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.